Navigation Links
Hadasit Bio-Holdings' Portfolio Companies Receive Funding to Support Clinical Trial Preparations and Obtain Regulatory Approvals in U.S. and Europe
Date:1/22/2013

JERUSALEM, Jan. 22, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, announced today that two of its portfolio companies, ProtAb and Enlivex, have received approximately $700,000 in convertible loans from Hadasit Bio-Holdings and its partners.  ProtAb received $435,000 and Enlivex received approximately $268,000 (NIS 1 million).

Ophir Shahaf , Chief Executive Officer of Hadasit Bio-Holdings, commented, "This recent influx of financing is intended to support and supplement the ongoing research and advancements within both companies. In regards to ProtAb, our partners at Clal Biotechnology Industries and Pontifax have also made proportionate financial commitments in an effort to fund the company in this same regard.  With the allocation of this capital, we aspire to develop a new form of treatment for autoimmune diseases that will activate the body's natural anti-inflammatory pathways.  ProtAb's activities are already focused on pin-pointing the mechanism of action for this treatment and preparing for clinical trials."

Mr. Shahaf continued, "At Enlivex, a company in which Hadasit currently holds a 92% stake, the funding was provided entirely by Hadasit Bio-Holdings.  This funding will help Enlivex continue to develop its unique solution for the prevention of Graft versus Host Disease (GVHD) for patients undergoing bone marrow transplants, for which no effective cure currently exists.  Throughout 2013, we anticipate Enlivex to obtain orphan drug status in Europe and the U.S., present clinical plans for FDA approval, as well as make preparations for a multi-center Phase II trial.  We extensively analyzed their progr
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems, LLC Cites Broad Applications of its 2013 Harvest of Uniquely Valuable Hemp Oil
2. VWR International, LLC Expands European Portfolio With Acquisitions Of Labonord SAS And Switch BVBA
3. Medical Marijuana Inc. Portfolio Company CanChew BioTechnologies Inc. Announces Final Three Days for Market Survey and Free Product Trial Registration
4. SAFC Expands PharmaGrade Raw Materials Portfolio for Biopharmaceutical Manufacturing
5. Positioning Strategies Effectively Minimize Cannibalization of a Legacy Brand When Expanding a Product Portfolio
6. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
7. Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
8. Intrepid Investment Bankers LLC Advises A-Med Health Care in the Sale of its Specialty Pharmacy Assets to Modern HC Pharmacy, Inc., a portfolio company of Altamont Capital Partners
9. PhytoSPHERE Systems, a Medical Marijuana Inc Portfolio Company, to Bring Production Facilities to Europe through Canipa Holdings.
10. Kimberly-Clark Health Care Receives FDA Clearance For KIMGUARD ONE-STEP Sterilization Wrap Portfolio With One-Year Maintenance Of Package Integrity And Amsco V-PRO maX (Flexible Cycle)
11. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
(Date:5/22/2015)... , May 22, 2015 ... Assay Market by Product (Consumables, Instruments, Services), by Test ... (ELISA, Chromatography, Flow Cytometry), by End Users - Global ... Assays Market is expected to reach $736.85 Million by ... CAGR of 10.25%. Browse 71 market ...
(Date:5/22/2015)... BOSTON , May 22, 2015  In a ... in the U.S., T1D Exchange researchers conclude ... in type 1 diabetes across all age groups, but ... the most up-to-date picture of diabetes treatment, underscoring the ... therapies and technologies that can help type 1 patients ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
(Date:5/22/2015)... Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they are ... cosmetic, restorative and other dental treatments. At consultations, ... interest them. Questions regarding what certain treatments can ... also be covered during this initial appointment. If ...
(Date:5/22/2015)... Medivo, Inc., a leader in lab data analytics, ... in ‘Baby Boomers’ Screened for HCV Following the 2012 CDC ... at Digestive Disease Week, May 16-19, 2015. , The ... members Carol Smyth, MB; Jason Bhan, MD; Tatiana Sorokina, MSc; ... Nancy Reau, MD from the University of Chicago, Chicago, IL. ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A ... at the American Society of Clinical Oncology (ASCO)’s ... improved survival rates for those patients who received ... regimen of pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is ... and it is already routinely used to treat ...
(Date:5/22/2015)... 22, 2015 DMG Productions announces the ... to broadcast on Friday, May 29, 2015 at 7:30 ... , In this episode Innovations will explore Interstate Restoration, ... business quickly through disaster recovery and restoration. , Additionally, ... works collaboratively to develop and deliver training and education ...
(Date:5/22/2015)... Phoenix, AZ (PRWEB) May 22, 2015 ... Special Olympics, Parker and Sons is offering to donate ... for installing an AC unit or water softening system. ... their behalf; Parker and Sons gets business; and the ... , The Special Olympics helps over 4.4 million ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... it is not. Yet its,success is none-the-less impressive. ... both worldwide and in the,U.S. since the turn ... for virtual,reality in surgery, medical education, therapy and ... Virtual Reality Market in the US Healthcare,Sector: Markets ...
... Oct. 19 How far can a bright, ... for one super smile could take YOU,all the ... at the People,s,Choice Awards. Listen to this ... journalists can access video, audio, text, graphics and,photos ...
... to fumes at home less likely to pass exams, research ... is secondhand smoke a threat to teen health, it can ... , Researchers at Temple University found that 16- and 18-year-olds ... likely to pass standardized tests than their peers. , They ...
... With safety issues making,headlines, pharmaceutical and ... Organizations are relying on their quality function,to ... Proper,staffing of quality roles is just one ... study by pharmaceutical benchmarking leader Best,Practices, LLC ...
... Single-Payer ... Healthcare, ... thanks Al Gore for,his forceful new words in support of the ... and that is,succeeding in nearly every other industrialized democracy. The ...
... MENTOR, Ohio, Oct. 19 STERIS Corporation,(NYSE: ... its fiscal 2008 second,quarter earnings release before the ... conference call at 10:00 a.m. Eastern time. The ... at http://www.steris-ir.com or via phone,by dialing ...
Cached Medicine News:Health News:Virtual Reality Technology Finds Ready and Willing Market in Healthcare 2Health News:Secondhand Smoke Hurts Kids' Grades 2Health News:Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance 2Health News:National Nurses Movement Lauds Al Gore for Leadership on Single-Payer Healthcare 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call 2Health News:STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call 3
...
To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps. - Also available in Titanium...
The CGAL gonioscopic contact glass was designed by Roussel and Fankhauser for,laser treatments of the chamber angle. It reduces the laser spot by a factor of 1.5 as compared to a Goldmann Glass....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
Medicine Products: